Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin as UV Protectant in Patients at Risk for Melanoma
NCT04066725Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jul 2019
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in cutaneous melanoma (CM), sponsored by University of Utah. Started Jul 2019; status: completed.
02
Drugs
aspirin
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT04066725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066725.